ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

Cancer Program Progress Detailed

March 5, 1976

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976